StockCIK 1623526

Stoke Therapeutics, Inc. (STOK): Insider Trades and Fund Holdings

In the past 12 months, Stoke Therapeutics, Inc. insiders reported 0 open-market purchases worth $0 and 6 sales worth $861K; 3 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$861KSold by insiders, 12 months

0Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 2, 2026.

Recent STOK insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Oct 2	Oct 1	Barry TichoCHIEF MEDICAL OFFICER	CHIEF MEDICAL OFFICER	▼ SELL10b5-1	1,051	26.16	$27K	−5.2%	Form 4 ↗
Oct 2	Oct 2	Jonathan AllanGeneral Counsel	General Counsel	▼ SELL10b5-1	627	26.33	$17K	−3.0%	Form 4 ↗
Sep 3	Sep 1	Barry TichoCHIEF MEDICAL OFFICER	CHIEF MEDICAL OFFICER	▼ SELL10b5-1	5,545	30.67	$170K	−22%	Form 4 ↗
Aug 18	Aug 18	Edward M. Md KayeDirector	Director	▼ SELL	12,567	32.03	$403K	−9.2%	Form 4 ↗
Aug 18	Aug 18	Barry TichoCHIEF MEDICAL OFFICER	CHIEF MEDICAL OFFICER	▼ SELL	4,767	32.03	$153K	−16%	Form 4 ↗
Aug 18	Aug 18	Jonathan AllanGeneral Counsel	General Counsel	▼ SELL	2,861	32.03	$92K	−12%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Bought	Sells	Sold	Latest
Barry Ticho	CHIEF MEDICAL OFFICER	$0	3	$350K	Oct 2, 2026
Jonathan Allan	General Counsel	$0	2	$108K	Oct 2, 2026
Edward M. Md Kaye	Director	$0	1	$403K	Aug 18, 2026

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →